Abstract
A new laser nephelometric technique for the measurement of the alternative complement pathway fragment Ba has been developed. Activation of the alternative complement pathway was assessed in 16 patients with Gram negative bacteraemia, six with Gram positive bacteraemia, 20 with rheumatoid arthritis, and 18 healthy subjects. Patients with Gram negative bacteraemia had significantly higher values of Ba (median 14.8%) than controls (9.3%) (p less than 0.01), while patients with Gram positive bacteraemia and rheumatoid arthritis had values similar to those of controls (10.1% and 9.5%). The technique proved sensitive and precise, and is suitable for the routine laboratory evaluation of complement activation through the alternative pathway.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown E. J., Joiner K. A., Frank M. M. The role of complement in host resistance to bacteria. Springer Semin Immunopathol. 1983;6(4):349–360. doi: 10.1007/BF02116279. [DOI] [PubMed] [Google Scholar]
- Fearon D. T., Ruddy S., Schur P. H., McCabe W. R. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med. 1975 May 1;292(18):937–940. doi: 10.1056/NEJM197505012921802. [DOI] [PubMed] [Google Scholar]
- Krick E. H., De Heer D. H., Kaplan R. A., Arroyave C. M., Vaughan J. H. Metabolism of factor B of serum complement in rheumatoid arthritis. Clin Exp Immunol. 1978 Oct;34(1):1–9. [PMC free article] [PubMed] [Google Scholar]
- Lachmann P. J., Hughes-Jones N. C. Initiation of complement activation. Springer Semin Immunopathol. 1984;7(2-3):143–162. doi: 10.1007/BF01893018. [DOI] [PubMed] [Google Scholar]
- Lambert P. H., Nydegger U. E., Perrin L. H., McCormic J., Fehr K., Miescher P. A. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid. Rheumatology. 1975;6:52–59. [PubMed] [Google Scholar]
- Pangburn M. K., Müller-Eberhard H. J. The alternative pathway of complement. Springer Semin Immunopathol. 1984;7(2-3):163–192. doi: 10.1007/BF01893019. [DOI] [PubMed] [Google Scholar]
- Perrin L. H., Lambert P. H., Miescher P. A. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest. 1975 Jul;56(1):165–176. doi: 10.1172/JCI108065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruddy S., Gigli I., Austen K. F. The complement system of man. 4. N Engl J Med. 1972 Sep 28;287(13):642–646. doi: 10.1056/NEJM197209282871306. [DOI] [PubMed] [Google Scholar]
- Vergani D., Bevis L., Nasaruddin B. A., Mieli-Vergani G., Tee D. E. Clinical application of a new nephelometric technique to measure complement activation. J Clin Pathol. 1983 Jul;36(7):793–797. doi: 10.1136/jcp.36.7.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vergani D. Complement. Diabet Med. 1986 Jul-Aug;3(4):306–311. doi: 10.1111/j.1464-5491.1986.tb00769.x. [DOI] [PubMed] [Google Scholar]
- Weigle W. O., Goodman M. G., Morgan E. L., Hugli T. E. Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol. 1983;6(2-3):173–194. doi: 10.1007/BF00205872. [DOI] [PubMed] [Google Scholar]
- Whicher J. T. The value of complement assays in clinical chemistry. Clin Chem. 1978 Jan;24(1):7–22. [PubMed] [Google Scholar]
- Zvaifler N. J. Rheumatoid synovitis. An extravascular immune complex disease. Arthritis Rheum. 1974 May-Jun;17(3):297–305. doi: 10.1002/art.1780170315. [DOI] [PubMed] [Google Scholar]